Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma

doi:10.3748/wjg.14.5210

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5340)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

461

HTML

4638

Figures (1-3)

122

Tables (1-3)

119

Sum=5340

Sep 7, 2008 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (96)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Sep 7, 2008; 14(33): 5210-5216
Published online Sep 7, 2008. doi: 10.3748/wjg.14.5210

Full Size Figure Download Figure

Figure 3 Functioning and symptom scales of the EORTC QLQ-30. First, third and sixth cycles: At the end of the first, third and sixth chemotherapeutic cycles; 1 mo: 1 mo after completion of chemotherapy. An improvement of more than 10 points was found in global QOL, physical and cognitive as well as emotional functioning, whereas symptoms such as pain were decreased by more than 18 points after completion of chemotherapy.

Citation: Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP, Pan BR. Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma. World J Gastroenterol 2008; 14(33): 5210-5216
URL: https://www.wjgnet.com/1007-9327/full/v14/i33/5210.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5210